What's Happening?
Dutch startup Vivici has been awarded €12.5 million ($14.4 million) by the European Innovation Council (EIC) Accelerator Program to enhance its production of dairy proteins through precision fermentation. This funding, a combination of grant and equity
investment, will support Vivici's efforts to scale its operations. Formed by Fonterra and DSM-Firmenich in December 2022, Vivici has quickly advanced in the field by integrating technology from Danish startup Enduro Genetics, which has significantly improved production efficiency. The company has also achieved regulatory milestones, including FDA GRAS status for beta-lactoglobulin and self-GRAS status for lactoferrin. Vivici is collaborating with European co-manufacturers and has partnered with Liberation Bioindustries to produce its proteins in Indiana, USA, and is exploring further expansion in the UAE.
Why It's Important?
Vivici's advancements in precision fermentation represent a significant step forward in the alternative protein market, which is crucial for addressing global food security and sustainability challenges. By improving production efficiency and achieving regulatory approvals, Vivici is well-positioned to meet the growing demand for sustainable protein sources. This development could have a substantial impact on the U.S. market, particularly as Vivici plans to produce its proteins domestically. The funding and partnerships indicate strong confidence in Vivici's technology and its potential to disrupt traditional dairy protein production, offering a more sustainable and scalable alternative.
What's Next?
Vivici's next steps involve scaling up production capabilities and expanding its market presence. The company is likely to focus on establishing a robust supply chain and increasing its production capacity in the U.S. and internationally. Stakeholders, including investors and industry partners, will be closely monitoring Vivici's progress as it seeks to commercialize its precision-fermented proteins. The success of these efforts could encourage further investment in the alternative protein sector and drive innovation in sustainable food production technologies.
